Skip to main content

Parallel Advisors, LLC

Position in RDY — Dr Reddys Laboratories Ltd

CIK 1690010 SAN FRANCISCO, CA

Position in RDY

as of Mar 31, 2026 · filed May 7, 2026
Position Value
$1,221,196
+$296,775 QoQ
Shares Held
88,173
+33.9% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in RDY Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

Parallel Advisors, LLC holds $7,470,447 across 34 Drug Manufacturers - Specialty & Generic names. RDY ranks #2 (16.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
2 RDY
Dr Reddys Laboratories Ltd
This page
88,173 $1,221,196

All Filings in RDY

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $1,221,196 88,173
2025-12-31 $924,421 65,842
2025-09-30 $1,100,226 78,700
2025-06-30 $1,178,953 78,440
2025-03-31 $647,167 49,065
2024-12-31 $1,149,354 72,790
2024-09-30 $1,157,745 14,572
2024-06-30 $946,432 12,422
2024-03-31 $803,329 10,952
2023-12-31 $453,244 6,514
2023-09-30 $410,381 6,137
2023-06-30 $278,567 4,414
2023-03-31 $239,618 4,209
2022-12-31 $158,613 3,065
2022-09-30 $290,539 5,551
2022-06-30 $249,033 4,496
2022-03-31 $216,120 3,878
2021-12-31 $234,429 3,584
2021-09-30 $249,746 3,834
2021-06-30 $277,647 3,777
2021-03-31 $219,592 3,577
2020-12-31 $256,929 3,604
2020-09-30 $283,317 4,073
2020-06-30 $210,767 3,976
2020-03-31 $192,414 4,771